Lasofoxifene as a potential treatment for ER plus metastatic breast cancer.

被引：4
|
作者：
Laine, Muriel
Fanning, Sean William
Greene, Marianne
Chang, Ya-fang
Phung, Linda
Tan, Tina T.
Hiipakka, Richard
Komm, Barry
Greene, Geoffrey
机构：
[1] Univ Chicago, Chicago, IL 60637 USA
[2] Sermonix, Philadelphia, PA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.1056
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1056
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer
    Laine, Muriel
    Fanning, Sean W.
    Chang, Ya-Fang
    Green, Bradley
    Greene, Marianne E.
    Komm, Barry
    Kurleto, Justyna D.
    Phung, Linda
    Greene, Geoffrey L.
    BREAST CANCER RESEARCH, 2021, 23 (01)
  • [2] Lasofoxifene as a potential treatment for therapy-resistant ER-positive metastatic breast cancer
    Muriel Lainé
    Sean W. Fanning
    Ya-Fang Chang
    Bradley Green
    Marianne E. Greene
    Barry Komm
    Justyna D. Kurleto
    Linda Phung
    Geoffrey L. Greene
    Breast Cancer Research, 23
  • [3] Lasofoxifene efficacy in a mammary intraductal ( MIND) xenograft model of ERα plus breast cancer.
    Laine, Muriel
    Greene, Marianne
    Chang, Ya-fang
    Phung, Linda
    Hiipakka, Richard
    Komm, Barry
    Greene, Geoffrey
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Characterization of mutational processes in ER plus metastatic breast cancer.
    Buendia-Buendia, Jorge
    Cohen, Ofir
    Kim, Dewey
    Jain, Esha
    Winer, Eric P.
    Lin, Nancy U.
    Wagle, Nikhil
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Lasofoxifene as a potential treatment for aromatase inhibitor resistant ER positive breast cancer
    Laine, Muriel
    Greene, Marianne E.
    Leng, Tiffany
    Kurleto, Justyna D.
    Li, Sophia
    Komm, Barry
    Greene, Geoffrey L.
    CANCER RESEARCH, 2022, 82 (04)
  • [6] Lasofoxifene as a potential treatment for aromatase inhibitor-resistant ER-positive breast cancer
    Laine, Muriel
    Greene, Marianne E.
    Kurleto, Justyna D.
    Bozek, Grazyna
    Leng, Tiffany
    Huggins, Rosemary J.
    Komm, Barry S.
    Greene, Geoffrey L.
    BREAST CANCER RESEARCH, 2024, 26 (01)
  • [7] New treatments for ER plus breast cancer.
    Chang, SB
    Miron, P
    Kung, AL
    Miron, A
    Iglehart, JD
    BREAST CANCER RESEARCH AND TREATMENT, 2004, 88 : S251 - S251
  • [8] Management of metastatic ER plus breast cancer
    Johnston, R. D.
    CANCER RESEARCH, 2017, 77
  • [9] Safety of limited dose modifications for palbociclib associated neutropenia in ER plus metastatic breast cancer.
    Dominick, Anthony
    O'Dea, Anne
    Khan, Qamar J.
    Kimler, Bruce F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [10] Mitoxantrone in the treatment of metastatic breast cancer.
    Bukavin, AS
    EXPERIMENTAL ONCOLOGY, 1996, 18 (03): : 280 - 283
12345